PACTR201709002592834
Completed
未知
A randomized controlled trial of pregnancy outcome of sequential versus day 3 and day 5 embryo transfers in cases with recurrent implantation failure
Airforce specialized hospital0 sites210 target enrollmentSeptember 7, 2017
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- Pregnancy and Childbirth
- Sponsor
- Airforce specialized hospital
- Enrollment
- 210
- Status
- Completed
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Age 35 years or less
- •Normal endometrial cavity on hysteroscopy
- •Recurrent (2 or more) implantation failure
- •Negative thrombophilia screening
- •No hydrosalpinx
- •No endometriosis
- •Day 3 FSH \< 10IU/L and Estradiol \<80 pg/mL
- •Antimullerian hormone 1\-3 ng/mL
- •Availability of at least 5 embryos on postfertilization check
Exclusion Criteria
- •Patients not fulfilling the inclusion criteria
- •Poor or over responders in a previous cycle or by ovarian reserve tests.
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
Not Applicable
A randomised controlled trial of a preconception clinic in BarnsleyPregnancy and childbirth: PregnancyPregnancy and ChildbirthPregnancyISRCTN28035939HS R&D Regional Programme Register - Department of Health (UK)200
Active, not recruiting
Not Applicable
Clinical Study to compare the effect of two different vaginal application forms of the hormone progesterone (Cyclogest® Pessary and Crinone® 8% Gel) on pregnancy rates after artificial fertilization.uteal phase support after IVFTherapeutic area: Diseases [C] - Female diseases of the urinary and reproductive systems and pregancy complications [C13]EUCTR2013-001105-81-BGActavis Group PTC ehf.766
Active, not recruiting
Phase 1
Clinical Study to compare the effect of two different vaginal application forms of the hormone progesterone (Cyclogest® Pessary and Crinone® 8% Gel) on pregnancy rates after artificial fertilization.uteal phase support after IVFTherapeutic area: Diseases [C] - Female diseases of the urinary and reproductive systems and pregancy complications [C13]EUCTR2013-001105-81-CZActavis Group PTC ehf.766
Active, not recruiting
Not Applicable
Clinical Study to compare the effect of two different vaginal application forms of the hormone progesterone (Cyclogest® Pessary and Crinone® 8% Gel) on pregnancy rates after artificial fertilization.EUCTR2013-001105-81-HUActavis Group PTC ehf.766
Active, not recruiting
Phase 1
Clinical Study to compare the effect of two different vaginal application forms of the hormone progesterone (Cyclogest® Pessary and Crinone® 8% Gel) on pregnancy rates after artificial fertilization.uteal phase support after IVFTherapeutic area: Diseases [C] - Female diseases of the urinary and reproductive systems and pregancy complications [C13]EUCTR2013-001105-81-BEActavis Group PTC ehf.766